These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 4137723)
1. In vivo kinetic studies in human myeloma. Pileri A; Tarocco RP Haematologica; 1974 Mar; 59(1):10-24. PubMed ID: 4137723 [No Abstract] [Full Text] [Related]
2. [Immunofluorescence optical studies for the differentiation of monoclonal and polyclonal increases in immunoglobulin producing bone marrow cells]. Morell A; Mosimann W; Skvaril F; Barandun S Schweiz Med Wochenschr; 1974 Sep; 104(39):1395-6. PubMed ID: 4214489 [No Abstract] [Full Text] [Related]
3. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal]. Villiamey J; Bouvet JP; Di Menza C; Boccara M Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506 [No Abstract] [Full Text] [Related]
4. Mouse bone marrow lymphocytes and their differentiation. Ryser JE; Vassalli P J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258 [No Abstract] [Full Text] [Related]
5. Two myeloma globulins IgG1-kappa and IgG1-lambda, from a single patient (Im). II. Their common cellular origin as revealed by immunofluorescence studies. Bouvet JP; Buffe D; Oriol R; Liacopoulos P Immunology; 1974 Dec; 27(6):1095-101. PubMed ID: 4141694 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients. Matzner Y; Benbassat J; Polliack A Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296 [No Abstract] [Full Text] [Related]
8. The production of interferon by malignant plasma cells from patients with multiple myeloma. Epstein LB; Salmon SE J Immunol; 1974 Mar; 112(3):1131-8. PubMed ID: 4359784 [No Abstract] [Full Text] [Related]
9. DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy. Alberts DS; Golde DW Cancer Res; 1974 Nov; 34(11):2911-4. PubMed ID: 4424360 [No Abstract] [Full Text] [Related]
10. [Proliferation of bone marrow and peripheral blood cells in leukemia and under normal conditions (review of the literature)]. Kozinets GI; Rapoport GL Probl Gematol Pereliv Krovi; 1972 Feb; 17(2):55-62. PubMed ID: 4558982 [No Abstract] [Full Text] [Related]
11. Correlation of proliferative and clonogenic tumor cells in multiple myeloma. Karp JE; Burke PJ; Saylor PL; Humphrey RL Cancer Res; 1984 Sep; 44(9):4197-200. PubMed ID: 6744329 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Pote A; Zwizinski C; Simon EE; Meleg-Smith S; Batuman V Am J Kidney Dis; 2000 Oct; 36(4):735-44. PubMed ID: 11007675 [TBL] [Abstract][Full Text] [Related]
13. Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient. Wolfenstein-Todel C; Franklin EC; Rudders RA J Immunol; 1974 Mar; 112(3):871-6. PubMed ID: 4811968 [No Abstract] [Full Text] [Related]
14. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia. Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486 [No Abstract] [Full Text] [Related]
15. Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Greipp PR; Kyle RA Blood; 1983 Jul; 62(1):166-71. PubMed ID: 6407546 [TBL] [Abstract][Full Text] [Related]